Selected Grants
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants with Moderate to Severe Hidradenitis Suppurativa
Clinical TrialPrincipal Investigator · Awarded by Lilly USA, LLC · 2024 - 2028Sonoma SBT777101-02
Clinical TrialPrincipal Investigator · Awarded by Sonoma Biotherapeutics, Inc. · 2024 - 2027A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
Clinical TrialPrincipal Investigator · Awarded by AbbVie Inc. · 2024 - 2027UCB Hidradenitis Suppurativa - Extention
Clinical TrialPrincipal Investigator · Awarded by UCB Pharma, Inc. · 2021 - 2025Sex hormones in Hidradenitis Suppurativa
ResearchPrincipal Investigator · Awarded by Dermatology Foundation · 2020 - 2024External Relationships
- Eli Lilly & Co.
- IDEOM
- Novartis pharmaceuticals
- Skin of Color Society
- UCB Pharma
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.